Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

Hydronopol substituted benzimidazolone and quinazolinone derivatives as agonists on human ORL1 receptors

US Patent 7851630 · Granted Dec 14, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Maresins for use in the treatment of CNS injuries2023
Fused heterocyclic derivatives as S1P modulators2020
Fused heterocyclic derivatives as S1P modulators2017
Fused heterocyclic derivatives as S1P modulators2015
Treatment of neural diseases or conditions2015
1H-imidazole derivatives as cannabinoid CB2 receptor modulators2015
Fused heterocyclic derivatives as S1P modulators2014
Amides as inhibitors of human secreted phospholipase A22014
1H-imidazole derivative having CB1, agonistic, CB1 partial agonistic or CB1 anta2014
Treatment of neural diseases or conditions2014
Phospholipase A2 inhibitors and their use in treating neurological injury and di2013
Combination preparations comprising bifeprunox and a dopamine agonist2012